Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02

Christos Tziotzios(Guy's Hospital), Christos Petridis(Guy's Hospital), Nick Dand(Guy's Hospital), Chrysanthi Ainali(Guy's Hospital), Jake Saklatvala(Guy's Hospital), Venu Pullabhatla(Guy's and St Thomas' NHS Foundation Trust), Alexandros Onoufriadis(Guy's Hospital), Rashida Pramanik(Guy's and St Thomas' NHS Foundation Trust), David Baudry(Guy's Hospital), Sang Hyuck Lee(King's College London), Kristie Wood(Guy's and St Thomas' NHS Foundation Trust), Lu Liu(St Thomas' Hospital), Seth Seegobin(Guy's Hospital), Gregory Michelotti(Metabolon (United States)), Su M. Lwin(Guy's Hospital), Evangelos Christou(Guy's Hospital), Charles Curtis(Guy's and St Thomas' NHS Foundation Trust), Emanuele de Rinaldis(Guy's and St Thomas' NHS Foundation Trust), Alka Saxena(Guy's and St Thomas' NHS Foundation Trust), Susan Holmes(Queen Elizabeth University Hospital), Matthew Harries(Salford Royal NHS Foundation Trust), Ioulios Palamaras(The Royal Free Hospital), Fiona Cunningham(Queen Elizabeth University Hospital), G. Parkins(Queen Elizabeth University Hospital), Manjit Kaur(Solihull Hospital), Paul Farrant(University Hospitals Sussex NHS Foundation Trust), A.J.G. McDonagh(Royal Hallamshire Hospital), Andrew G. Messenger(Royal Hallamshire Hospital), Jennifer Jones(The Royal Free Hospital), Victoria Jolliffe(Barts Health NHS Trust), Iaisha Ali(Imperial College Healthcare NHS Trust), Michael R. Ardern‐Jones(University Hospital Southampton NHS Foundation Trust), Charles D. Mitchell(Portsmouth Hospitals NHS Trust), Nigel Burrows(Cambridge University Hospitals NHS Foundation Trust), Ravinder Atkar(Cambridge University Hospitals NHS Foundation Trust), Cedric C. Banfield(Peterborough City Hospital), A.B. Alexandroff(Leicester Royal Infirmary), Caroline Champagne(Churchill Hospital), Hywel Cooper(Portsmouth Hospitals NHS Trust), Sérgio Vañó-Galván(Universidad de Alcalá), A.M. Molina‐Ruiz(Hospital Universitario Fundación Jiménez Díaz), Nerea Ormaechea Pérez(Biogipuzkoa Health Research Institute), Girish K. Patel(Hywel Dda University Health Board), A. E. Macbeth(Norfolk and Norwich University Hospitals NHS Foundation Trust), Melanie C. Page(Norfolk and Norwich University Hospitals NHS Foundation Trust), Alyson Bryden(Ninewells Hospital), Megan Mowbray(Queen Margaret Hospital), Shyamal Wahie(County Durham and Darlington NHS Foundation Trust), Keith Armstrong(University of Ulster), Nicola Cooke(Northern Health and Social Care Trust), Mark Goodfield(Chapel Allerton Hospital), Irene Man(Surrey and Sussex Healthcare NHS Trust), David de Berker(University Hospitals Bristol NHS Foundation Trust), Giles Dunnill(University Hospitals Bristol NHS Foundation Trust), Anita Takwale(Gloucestershire Hospitals NHS Foundation Trust), Archana S. Rao(Kingston Hospital), Tee-Wei Siah(Royal Victoria Infirmary), Rodney Sinclair(The University of Melbourne), Martin Wade(London Clinic), Ncoza C. Dlova(Nelson Mandela Academic Hospital), Jane Setterfield(Guy's Hospital), Fiona Lewis(Guy's Hospital), Kapil Bhargava(Guy's Hospital), Niall Kirkpatrick(Chelsea and Westminster Hospital), Xavier Estivill(Hospital Universitario Dexeus), Catherine M. Stefanato(St Thomas' Hospital), Carsten Flohr(Guy's Hospital), Timothy D. Spector(King's College London), Fiona M. Watt(Guy's Hospital), Catherine Smith(Guy's Hospital), Jonathan N. Barker(Guy's Hospital), David A. Fenton(Guy's Hospital), Michael A. Simpson(Guy's Hospital), John A. McGrath(Guy's Hospital)
Nature Communications
March 8, 2019
Cited by 119Open Access
Full Text

Abstract

Frontal fibrosing alopecia (FFA) is a recently described inflammatory and scarring type of hair loss affecting almost exclusively women. Despite a dramatic recent increase in incidence the aetiopathogenesis of FFA remains unknown. We undertake genome-wide association studies in females from a UK cohort, comprising 844 cases and 3,760 controls, a Spanish cohort of 172 cases and 385 controls, and perform statistical meta-analysis. We observe genome-wide significant association with FFA at four genomic loci: 2p22.2, 6p21.1, 8q24.22 and 15q2.1. Within the 6p21.1 locus, fine-mapping indicates that the association is driven by the HLA-B*07:02 allele. At 2p22.1, we implicate a putative causal missense variant in CYP1B1, encoding the homonymous xenobiotic- and hormone-processing enzyme. Transcriptomic analysis of affected scalp tissue highlights overrepresentation of transcripts encoding components of innate and adaptive immune response pathways. These findings provide insight into disease pathogenesis and characterise FFA as a genetically predisposed immuno-inflammatory disorder driven by HLA-B*07:02.


Related Papers

No related papers found

Powered by citation graph analysis